Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANGIODYNAMICS INCANGO · Entity 5275 | Director | July 15, 2026 | July 23, 2026 |
| AVITA Medical, Inc.RCEL · Entity 5905 | Director | June 03, 2026 | June 04, 2026 |
| GMR Solutions Inc.GMRS · Entity 5222 | Director | August 26, 2026 | August 28, 2026 |
| STEPAN COSCL · Entity 4733 | Director | May 08, 2026 | May 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANGIODYNAMICS INC
Report date July 15, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 116,921 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 11,887 · Balance 116,921 F1: The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.
AVITA Medical, Inc.
Report date June 03, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,225 |
Reported balance
After 2026-01-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-01-20 · Grant · Acquired 22,214 · Balance 73,225 F1: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026. F2: Includes unvested RSUs. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.77 · Expires 2036-01-20 | Direct | 16,133 |
Reported balance
After 2026-01-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-20 · Grant · Acquired 16,133 · Balance 16,133 F3: On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the "Grant Date") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026.
F2: Includes unvested RSUs.
F3: On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the "Grant Date") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026.
GMR Solutions Inc.
Report date August 26, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 976 |
Reported balance
After 2026-08-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-26 · Grant · Acquired 976 · Balance 976 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer Class A common stock ("Class A Common Stock"). The RSUs will be settled in either Class A Common Stock or cash (or a combination thereof) at the Issuer's discretion. F2: These RSUs vest on the earlier of (i) July 1, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders of the Issuer following the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer Class A common stock ("Class A Common Stock"). The RSUs will be settled in either Class A Common Stock or cash (or a combination thereof) at the Issuer's discretion.
F2: These RSUs vest on the earlier of (i) July 1, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders of the Issuer following the date of grant.
STEPAN CO
Report date May 08, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,477 |
Reported balance
After 2026-05-08 transaction · row 1
1 source rowRow 1 · 2026-05-08 · Grant · Acquired 2,566 · Balance 16,477 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2026 Filed Aug 28, 2026 17:09 UTC | GMR Solutions Inc. GMRS · Entity 5222 | GrantRestricted Stock Units · Derivative | 976 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-103307 · tm2624312-1_4seq1.xml · derivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 976 Underlying: Class A Common Stock · 976 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer Class A common stock ("Class A Common Stock"). The RSUs will be settled in either Class A Common Stock or cash (or a combination thereof) at the Issuer's discretion. F2 · derivative.exercise_date: These RSUs vest on the earlier of (i) July 1, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders of the Issuer following the date of grant. F2 · derivative.expiration_date: These RSUs vest on the earlier of (i) July 1, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders of the Issuer following the date of grant. Read SEC document |
| July 15, 2026 Filed Jul 23, 2026 00:06 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 11,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-029341 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,921 F1 · shares: The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:39 UTC | GMR Solutions Inc. GMRS · Entity 5222 | GrantRestricted Stock Units · Derivative | 12,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-062693 · tm2614730-7_4seq1.xml · derivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,334 Underlying: Class A Common Stock · 12,334 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer Class A common stock ("Class A Common Stock"). The RSUs will be settled in either Class A Common Stock or cash (or a combination thereof) at the Issuer's discretion. F2 · derivative.exercise_date: These RSUs vest on the earlier of (i) May 12, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders of the Issuer following the date of grant. F2 · derivative.expiration_date: These RSUs vest on the earlier of (i) May 12, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders of the Issuer following the date of grant. Read SEC document |
| May 08, 2026 Filed May 12, 2026 23:27 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 2,566 | $52.61 | $134,997.26 |
DisclosureSEC source: 0000094049-26-000096 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,477 Read SEC document |
| January 20, 2026 Filed Jun 4, 2026 23:08 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 16,133 | $0.00 Strike: $3.77 | $0.00 |
DisclosureSEC source: 0001124181-26-000002 · ownership.xml · derivative · entry 2 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,133 Underlying: Common Stock · 16,133 shares Expires 2036-01-20 F3 · derivative.exercise_price: On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the "Grant Date") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026. Read SEC document |
| January 20, 2026 Filed Jun 4, 2026 23:08 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantCommon Stock | 22,214 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001124181-26-000002 · ownership.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,225 F1 · price: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| July 16, 2025 Filed Jul 18, 2025 22:06 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 17,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-026456 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,034 F1 · shares: The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| May 12, 2025 Filed May 14, 2025 00:34 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 2,500 | $54.26 | $135,655.00 |
DisclosureSEC source: 0001127602-25-014162 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,911 Read SEC document |
| January 21, 2025 Filed Jun 5, 2025 20:55 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 4,295 | $0.00 Strike: $8.73 | $0.00 |
DisclosureSEC source: 0000950170-25-082450 · ownership.xml · derivative · entry 2 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,295 Underlying: Common Stock · 4,295 shares Expires 2035-01-21 F3 · derivative.exercise_price: On January 6, 2025, the Board of Directors approved a grant of 4,295 options to acquire 4,295 shares of Common Stock to each of its non-executive directors, with a grant date of January 21, 2025 (the "Grant Date") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $8.73. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025. Read SEC document |
| January 21, 2025 Filed Jun 5, 2025 20:55 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantCommon Stock | 10,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-082450 · ownership.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,011 F1 · price: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 21, 2025. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 21:18 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 20,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-033633 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,359 F1 · shares: The acquisition of 20,541 shares of common stock of AngioDynamics, Inc.("AngioDynamics") represents 20,541 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 23:21 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 3,943 | $0.00 Strike: $9.51 | $0.00 |
DisclosureSEC source: 0000950170-24-070102 · ownership.xml · derivative · entry 2 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,943 Underlying: Common Stock · 3,943 shares Expires 2034-06-05 Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 23:21 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantCommon Stock | 9,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-070102 · ownership.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,989 F1 · price: Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| May 10, 2024 Filed May 14, 2024 21:02 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 1,396 | $89.53 | $124,983.88 |
DisclosureSEC source: 0001127602-24-015286 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,411 Read SEC document |
| July 19, 2023 Filed Jul 22, 2023 01:11 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 17,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-035722 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,818 F1 · shares: The acquisition of 17,041 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,041 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:38 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 2,646 | $0.00 Strike: $14.17 | $0.00 |
DisclosureSEC source: 0001209191-23-035440 · doc4.xml · derivative · entry 2 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,646 Underlying: Common Stock · 2,646 shares Expires 2033-06-06 F1 · shares: The reporting person may elect to acquire the Issuer's CHESS Depositary Interests ("CDIs") in place of common stock upon vesting of a Restricted Stock Unit ("RSU") or exercise of a Stock Option. CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of common stock and have all the rights and privileges of common stock. F4 · derivative.exercise_date: These Stock Options vest on the date 12 months following the grant date. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:38 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantCommon Stock | 6,175 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-035440 · doc4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,789 F1 · shares: The reporting person may elect to acquire the Issuer's CHESS Depositary Interests ("CDIs") in place of common stock upon vesting of a Restricted Stock Unit ("RSU") or exercise of a Stock Option. CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of common stock and have all the rights and privileges of common stock. F2 · price: Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date. F3 · balance_after: Includes unvested RSUs. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 16:15 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 1,325 | $94.32 | $124,974.00 |
DisclosureSEC source: 0001127602-23-013626 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,015 Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 22:25 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 5,395 | $0.00 Strike: $6.95 | $0.00 |
DisclosureSEC source: 0001209191-22-061283 · doc4.xml · derivative · entry 2 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,395 Underlying: Common Stock · 5,395 shares Expires 2032-12-12 F3 · derivative.exercise_date: These Stock Options vest on the date 12 months following the grant date. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 22:25 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantCommon Stock | 12,589 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-061283 · doc4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,614 F1 · price: Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 22:06 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 7,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-014352 · doc1.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,777 F1 · shares: The acquisition of 7,060 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 7,060 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/20/2023. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 11:09 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 1,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012618 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,690 Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:30 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 2,550 | $0.00 Strike: $12.18 | $0.00 |
DisclosureSEC source: 0001209191-21-071250 · doc4.xml · derivative · entry 4 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,550 Underlying: Common Stock · 2,550 shares Expires 2031-12-22 F5 · derivative.exercise_date: These Stock Options vest on the date 12 months following the grant date. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:30 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 4,925 | $0.00 Strike: $12.18 | $0.00 |
DisclosureSEC source: 0001209191-21-071250 · doc4.xml · derivative · entry 3 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,925 Underlying: Common Stock · 4,925 shares Expires 2031-12-22 F4 · derivative.exercise_date: These Stock Options vest in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:30 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantCommon Stock | 4,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-071250 · doc4.xml · nonDerivative · entry 2 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,025 F3 · price: Represents an award of RSUs that vest on the date 12 months following the grant date. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:30 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantCommon Stock | 8,675 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-071250 · doc4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,675 F1 · price: Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 23:08 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 5,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-013935 · doc1.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,717 F1 · shares: The acquisition of 5,738 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 5,738 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/21/2022. Read SEC document |
| April 27, 2021 Filed Apr 28, 2021 20:06 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 760 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014573 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,441 Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 23:28 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 15,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-013373 · doc1.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,979 F1 · shares: The acquisition of 15,323 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 15,323 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/14/2021. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 18:15 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 1,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014337 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,681 Read SEC document |
| July 17, 2019 Filed Jul 20, 2019 01:24 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 7,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-015037 · doc1.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,656 F1 · shares: The acquisition of 7,057 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 7,057 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/17/2020. Read SEC document |
| April 30, 2019 Filed May 2, 2019 18:59 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 1,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-016913 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 Read SEC document |
| July 18, 2018 Filed Jul 21, 2018 01:32 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 6,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-033089 · doc1.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,599 F1 · shares: The acquisition of 6,307 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 6,307 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/18/2019. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:32 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 1,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015346 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,491 Read SEC document |
| July 26, 2017 Filed Jul 28, 2017 19:43 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 7,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-029118 · doc1.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,292 F1 · shares: The acquisition of 7,976 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 7,976 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/26/2018. Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 18:33 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | PurchaseCommon Stock | 316 | $16.00 | $5,056.00 |
DisclosureSEC source: 0001140361-17-028594 · doc1.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316 Read SEC document |
| April 25, 2017 Filed Apr 27, 2017 20:15 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 1,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-015704 · form4.xml · nonDerivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,334 Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 21:58 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $16.12 | $0.00 |
DisclosureSEC source: 0001140361-16-085625 · doc1.xml · derivative · entry 1 REED JAN STERN · CIK 0001124181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2023-11-07 F1 · derivative.exercise_date: These stock options vest in four equal annual installments beginning on November 7, 2017, such that 25% of the options will vest on each of November 7, 2017, 2018, 2019 and 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.